Glycemic control modifies the association between microalbuminuria and c-reactive protein in Type 2 Diabetes Mellitus
Microalbuminuria and C-reactive protein reflect closely related components of the same disease process. The present study attempts to evaluate whether any association exists between C-reactive protein and microalbuminuria in Type 2 Diabetes Mellitus patients with poor and adequate glycemic control. It was observed that in diabetics with poor glycemic control, microalbuminuria showed a significant positive correlation with C-reactive protein and the prevalence of microalbuminuria was significantly more at elevated C-reactive protein levels. These parameters were not significant in subjects with adequately controlled disease. Further, there was a significant increase in levels of microalbuminuria in patients with poor glycemic control when compared to well-controlled diabetics at comparative levels of C-reactive protein. This study supports the hypothesis that endothelial dysfunction and inflammatory activity are involved in the pathogenesis of microalbuminuria and underscores the importance of glycemic control in the progression of inflammation in diabetes.
Key wordsMicroalbuminuria C-reactive protein Glycemic control Diabetes Mellitus
Unable to display preview. Download preview PDF.
- 5.American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003; 26 (Suppl 1); S94-S98.Google Scholar
- 8.Yudkin J, Forrest R, Jackson C. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1998; 2: 530–33.Google Scholar
- 16.Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care 1998; 20: 1183–97.Google Scholar
- 17.Coen DA Stehouwer, Mari-Anne Gall, Jos WR Twisk, Elisabeth Knudsen, Jeff J Emeis, Hans-Henrik Parving. Increased albumin excretion, endothelial dysfunction and chronic low-grade inflammation in Type 2 Diabetes. The American Diabetes Association Inc 2002.Google Scholar
- 19.Stehouwer C, Gall M, Twisk J, Knudsen E, Emeis J, Parving H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002; 51: 1157–65.PubMedCrossRefGoogle Scholar
- 23.Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. Creactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb Vasc Biol 1999; 19: 972–8.Google Scholar
- 24.Jager A, van Hinsbergh VWM, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CDA. von Willebrand factor, C-reactive protein and 5-year mortality in diabetic and nondiabetic subjects the Hoorn Study. Arterioscler. Thromb Vasc Biol 1999; 19: 3071–8.Google Scholar
- 28.Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HGT, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CDA, van Hinsbergh VWM. Amadori-albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy and localization in retinal capillaries. Diabetes 1999; 48: 2446–53.PubMedCrossRefGoogle Scholar